Hans Torben Mourits‐Andersen

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients

Claudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2005 · 174 citations

Life Sciences, Hematology, Immunology +14

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

Sif Gudbrandsdottir, Henrik Birgens, Henrik Frederiksen et al. · Blood · 2013 · 174 citations · Full text

Life Sciences, Hematology, Immunology +7

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 105 citations · Full text

Medicine, Hematology, Pharmacology +15

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis

Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn et al. · Cancer Medicine · 2018 · 45 citations · Full text

Medicine, Hematology, Pharmacology +16

A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry

Anne Ortved Gang, Michael Pedersen, Francesco d’Amore et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 30 citations · Full text

Medicine, Hematology, Oncology +15